Agenus (AGEN) Non-Current Debt (2010 - 2025)
Agenus' (AGEN) quarterly Non-Current Debt came in at $23.6 million in Q3 2025, up 1.94% quarter-over-quarter from $23.2 million in Q2 2025.
Agenus (AGEN) Non-Current Debt (2010 - 2025) Analysis & Trends
Agenus' Non-Current Debt history runs 16 years deep, the most recent figure standing at $23.6 million for Q3 2025.
- On a quarterly basis, Non-Current Debt changed N/A year-over-year to $23.6 million in Q3 2025; TTM through Sep 2025 was $23.6 million, a N/A change from a year earlier, with the FY2024 full-year figure at $30.5 million, up 138.67% from the prior year.
- Non-Current Debt grew to $23.6 million in Q3 2025 per AGEN's latest filing, from $23.2 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $32.8 million in Q1 2025 and bottomed at $12.6 million in Q4 2022.
- The 5-year median for Non-Current Debt is $12.8 million (2021), against an average of $18.2 million.
- Across the five-year window, Non-Current Debt plunged 32.15% in 2021 and soared 138.67% in 2024, its largest moves.
- Year by year, Non-Current Debt stood at $12.8 million in 2021, then fell by 1.86% to $12.6 million in 2022, then advanced by 1.46% to $12.8 million in 2023, then surged by 138.67% to $30.5 million in 2024, then slipped by 22.56% to $23.6 million in 2025.
- Per Business Quant, the three latest AGEN Non-Current Debt figures stand at $23.6 million (Q3 2025), $23.2 million (Q2 2025), and $32.8 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Agenus | 184.05 Mn | 177.29 Mn | 33.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 23.60 Mn |
| Jun 30, 2025 | 23.15 Mn |
| Mar 31, 2025 | 32.85 Mn |
| Dec 31, 2024 | 30.47 Mn |
| Dec 31, 2023 | 12.77 Mn |
| Sep 30, 2023 | 12.72 Mn |
| Jun 30, 2023 | 12.67 Mn |
| Mar 31, 2023 | 12.63 Mn |
| Dec 31, 2022 | 12.58 Mn |
| Dec 31, 2021 | 12.82 Mn |
| Sep 30, 2021 | 12.79 Mn |
| Jun 30, 2021 | 18.95 Mn |
| Mar 31, 2021 | 18.91 Mn |
| Dec 31, 2020 | 18.88 Mn |
| Sep 30, 2020 | 18.85 Mn |
| Jun 30, 2020 | 18.81 Mn |
| Mar 31, 2020 | 12.58 Mn |
| Dec 31, 2019 | 13.38 Mn |
| Dec 31, 2018 | 13.21 Mn |
| Sep 30, 2018 | 13.05 Mn |